BROWSE·page 450 of 1457

Browse EX-10 agreements

17,480 total material contract exhibits.


EX-10.1

Technology & Telecommunication Acquisition Corp

** **

AMENDMENT

TO THE

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Amendment No. 7 (this “Amendment”), dated as of August 20, 2026, to the Investment Management Trust Agreement (as defined below) is made by and between Technology & Telecommunication Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). All terms used but not defined herein shall have the meanings assigned to them in the Trust Agreement.

WHEREAS, the Company and the Trustee entered into an Investment Management Trust Agreement dated as of January 14, 2022 (as amended on by Amendment No. 1, Amendment No.2, Amendment No.3, Amendment No. 4 Amendment No. 5, and Amendment No. 6 thereto, the “Trust Agreement”);

WHEREAS, Section 1(i) of the Trust Agreement sets forth the terms that govern the liquidation of the Trust Account under the circumstances described therein;

…

EX-10.1·8-K·CIK 1900679·ACC 0001493152-26-040261·Filed Aug 26, 2026, 17:05 ET

EXHIBIT 10.1

Autonomix Medical, Inc.

AUTONOMIX MEDICAL, INC.

August 24, 2026

Holder of Common Stock Purchase Warrants

Re:         Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Autonomix Medical, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise all of the Series D-1 warrants and Series D-2 warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued to you on July 15, 2026 (the “Existing Warrants”), as set forth on the signature page hereto and currently held by you (the “Holder”). The issuance of the shares of Common Stock underlying the Existing Warrants (the “Warrant Shares”) has been registered for resale pursuant to the registration statement on Form S-3 (File No. 333-297760) (the “Registration Statement”). The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to this letter agreement, will be effective for the resale of the Warrant Shares.** **Capitalized terms not otherwise defined herein shall have the meanings set forth in the New Warran

…

EX-10.1·8-K·CIK 1617867·ACC 0001437749-26-029024·Filed Aug 26, 2026, 17:02 ET

IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE “CONFIDENTIAL INFORMATION”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****].

REAL ESTATE PURCHASE AND SALE AGREEMENT

THIS REAL ESTATE PURCHASE AND SALE AGREEMENT (the “Agreement”) is made and entered into as of the 16th day of August, 2026 (the “Effective Date”) by and between Unifi Manufacturing, Inc., a North Carolina corporation (the “Seller”), and ENOVUM DATA CENTERS CORP., a Canadian corporation and its permitted assigns (the “Buyer”) (Buyer and Seller are referred to herein individually as a “Party” and, together, the “Parties”).

STATEMENT OF PURPOSE

** **

A. Seller is the owner of that certain real property situated in Yadkin County, North Carolina and being more particularly described as follows:

…

EX-10.1·8-K/A·CIK 2042022·ACC 0001213900-26-094022·Filed Aug 26, 2026, 16:58 ET

EX-10.1

BIOMERICA INC

BIOMERICA, INC.

SECURITIES PURCHASE AGREEMENT

This SECURITIES Purchase Agreement (this “Agreement”) is dated as of August 20, 2026, by and between Biomerica, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, “Purchaser” and collectively the “Purchasers”).

Whereas, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

Now, Therefore, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

Article I

DEFINITIONS

…

EX-10.1·8-K·CIK 73290·ACC 0001493152-26-040251·Filed Aug 26, 2026, 16:54 ET

EX-10.2

BIOMERICA INC

** **

BIOMERICA, INC.

** **

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 20, 2026, by and between Biomerica, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agree as follows:

1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section 6(d).

…

EX-10.2·8-K·CIK 73290·ACC 0001493152-26-040251·Filed Aug 26, 2026, 16:54 ET

EX-10.1

NVIDIA CORP

CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

EXHIBIT 10.1

FORM OF RESIDUAL VALUE GUARANTY

This RESIDUAL VALUE GUARANTY (this “Guaranty”), dated as of [_____] (the “Execution Date”), is entered into by NVIDIA Corporation, a Delaware corporation (the “Guarantor”) and [_____], a Delaware limited liability company (“Landlord”) with reference to the following facts:

A.[***] (“Tenant”) and Landlord entered into that certain Lease Agreement dated as of the Execution Date (together with the Work Letter and other exhibits thereto, collectively, the “Lease”), in which Tenant agreed to lease certain real property located in the City of Piketon, State of Ohio (as more particularly described in the Lease) from Landlord upon and subject to the terms and conditions set forth therein.

…

EX-10.1·10-Q·CIK 1045810·ACC 0001045810-26-000075·Filed Aug 26, 2026, 16:36 ET

EXHIBIT 10.2

Endovia Health Sciences, Inc.

EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) is entered into as of August 20, 2026, and is effective as of June 8, 2026 (the “Effective Date”), by and between Splash Beverage Group, Inc., a Nevada corporation (the “Company”), and Michael Bondurant (the “Executive”).

RECITALS

WHEREAS, the Company desires to employ the Executive as its Interim Chief Operating Officer (“COO”) and to ensure the continued availability of the Executive’s services on the terms and conditions set forth herein;

WHEREAS, the Executive desires to be employed by the Company on such terms and conditions;

WHEREAS, the Company is a publicly traded corporation whose common stock is listed on a national securities exchange and is subject to the reporting requirements of the Securities Exchange Act of 1934 (the “Exchange Act”);

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to enter into this Agreement with the Executive; and

…

EX-10.2·8-K·CIK 1553788·ACC 0001731122-26-001152·Filed Aug 26, 2026, 16:30 ET

EXHIBIT 10.1

Endovia Health Sciences, Inc.

EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) is entered into as of August 20, 2026, and is effective as of June 8, 2026 (the “Effective Date”), by and between Splash Beverage Group, Inc., a Nevada corporation (the “Company”), and Brady Cobb (the “Executive”).

RECITALS

WHEREAS, the Company desires to employ the Executive as its Interim Chief Executive Officer (“CEO”) and to ensure the continued availability of the Executive’s services on the terms and conditions set forth herein;

WHEREAS, the Executive desires to be employed by the Company on such terms and conditions;

WHEREAS, the Company is a publicly traded corporation whose common stock is listed on a national securities exchange and is subject to the reporting requirements of the Securities Exchange Act of 1934 (the “Exchange Act”);

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to enter into this Agreement with the Executive; and

…

EX-10.1·8-K·CIK 1553788·ACC 0001731122-26-001152·Filed Aug 26, 2026, 16:30 ET

EXHIBIT 10.1

Z Squared Inc.

AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT

THIS AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), dated as of August 24, 2026, is made by and between Z SQUARED INC., a Delaware corporation (together with its successors and assigns, the “Company”), and Jeffery Harris (the “Executive”). Capitalized terms used but not defined herein have the meanings given to them in the Employment Agreement (as defined below).

** **

WHEREAS, the Company and the Executive are parties to that certain Executive Employment Agreement (the “Employment Agreement”), dated as of June 24, 2026 (the “Effective Date”), pursuant to which the Executive serves as the Chief Technology Officer of the Company;

** **

…

EX-10.1·8-K·CIK 1759186·ACC 0001185185-26-003730·Filed Aug 26, 2026, 16:30 ET

DEMAND PROMISSORY NOTE

** **

$450,000 August 26, 2026

** **

FOR VALUE RECEIVED, VEEA INC., a Delaware corporation (the “Company”), hereby promises to pay to the order of NLabs Inc., a Delaware corporation or such holder’s assigns (“Holder”), the principal sum of FOUR HUNDRED AND FIFTY THOUSAND DOLLARS AND NO CENTS ($450,000) (the “Principal Amount”) together with interest thereon from the date hereof to maturity at a simple interest at the rate of ten percent (10%) per annum, calculated on the basis of a 365-day year and actual days elapsed since the issuance of this Demand Promissory Note (this “Note”).

The Principal Amount is due on demand, and in the absence of any demand is due on December 31, 2026. All installments, prepayments, and other payments of principal and interest are payable to Holder in cash in immediately available funds to the account designed by Holder.

…

EX-10.2·8-K·CIK 1840317·ACC 0001213900-26-093996·Filed Aug 26, 2026, 16:30 ET

** **

DEMAND PROMISSORY NOTE

** **

$ 450,000 August 26, 2026

** **

FOR VALUE RECEIVED, VEEA INC., a Delaware corporation (the “Company”), hereby promises to pay to the order of NLabs Inc., a Delaware corporation or such holder’s assigns (“Holder”), the principal sum of FOUR HUNDRED AND FIFTY THOUSAND DOLLARS AND NO CENTS ($450,000) (the “Principal Amount”) together with interest thereon from the date hereof to maturity at a simple interest at the rate of ten percent (10%) per annum, calculated on the basis of a 365-day year and actual days elapsed since the issuance of this Demand Promissory Note (this “Note”).

The Principal Amount is due on demand, and in the absence of any demand is due on December 31, 2026. All installments, prepayments, and other payments of principal and interest are payable to Holder in cash in immediately available funds to the account designed by Holder.

…

EX-10.1·8-K·CIK 1840317·ACC 0001213900-26-093996·Filed Aug 26, 2026, 16:30 ET